Issuer:
|
BioMed Realty Trust, Inc. (the “Company”) | |
Symbol:
|
NYSE: BMR | |
Security:
|
Common stock, par value $0.01 per share | |
Size:
|
16,000,000 shares of common stock, representing an increase of 2,000,000 shares over the 14,000,000 shares described in the preliminary prospectus filed with the SEC on May 12, 2009 | |
Over-Allotment Option:
|
2,400,000 additional shares of common stock, representing 300,000 shares more than the 2,100,000 over-allotment shares described in the preliminary prospectus | |
Shares outstanding after the offering:
|
97,181,196 shares (99,581,196 shares if the over-allotment option is exercised in full) | |
Public offering price:
|
$10.40 per share | |
Trade date:
|
May 13, 2009 | |
Settlement and delivery date:
|
May 18, 2009 | |
Underwriting discounts and commissions:
|
$0.416 per share; $6,656,000 total ($7,654,400 if over-allotment option is exercised in full) | |
Proceeds to the Company, before expenses:
|
$9.984 per share; $159,744,000 total ($183,705,600 if over-allotment option is exercised in full) | |
Use of proceeds:
|
The Company expects the net proceeds of this offering to be approximately $159,444,000, after deducting the underwriting discounts and commissions and the Company’s estimated offering expenses. If the over-allotment option is exercised in full, the Company expects net proceeds of approximately $183,405,600. The Company will contribute the net proceeds of this offering to BioMed Realty, L.P., its operating partnership. The operating partnership intends to subsequently use the net proceeds of the offering to repay a portion of the outstanding indebtedness under our $600.0 million unsecured line of credit and for other general corporate and working capital purposes. | |
Lead Managers:
|
Raymond James & Associates, Inc. KeyBanc Capital Markets Inc. Morgan Stanley & Co. Incorporated UBS Securities LLC Wachovia Capital Markets, LLC Credit Suisse Securities (USA) LLC |
|
Co-Managers:
|
Deutsche Bank Securities Inc. Robert W. Baird & Co. Incorporated Oppenheimer & Co. Inc. Stifel, Nicolaus & Company, Incorporated FBR Capital Markets & Co. |
|
Relationships:
|
An affiliate of each of Raymond James & Associates, Inc., KeyBanc Capital Markets Inc., Wachovia Capital Markets, LLC and Credit Suisse Securities (USA) LLC is a lender under our $600.0 million unsecured line of credit. A portion of the net proceeds will be received by these affiliates because we intend to use the net proceeds to repay a portion of the outstanding borrowings under our $600.0 million unsecured line of credit. |